Epidemiological impact of a 20- or 21-valent pneumococcal conjugate vaccine in the Japan adult population: insights from a dynamic transmission model.
Publié: 2026-05-22
Expert review of vaccines
MediLens Indexé: 2026-05-23
This study evaluates the impact of pneumococcal vaccination strategies in Japan, comparing PCV20 and V116 with PPSV23. Using a dynamic transmission model, it finds that switching to PCV20 could reduce invasive pneumococcal disease (IPD) by up to 0.3%, while V116 could reduce it by up to 2.6%. Exp...
Lire sur PubMed